medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2015, Number 3

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2015; 13 (3)

Paraneoplastic Dermatoses

Garza CJI, Ocampo CJ

Language: Spanish
References: 25
Page: 220-227
PDF size: 229.23 Kb.


ABSTRACT

Paraneoplasic dermatoses consist of a heterogeneous group of clinical cutaneous manifestations representing the distant effect caused by a malignat neoplasm. They represent the second most common paraneoplastic syndrome. Cutaneous paraneoplasic dermatoses can present as the first sign of malignancy, even years before diagnosis of malignant neoplasm, or they can herald the recurrence. Their correct diagnosis can contribute to achieve early detection of malignancy and thus a better prognosis. More than 30 paraneoplastic dermatoses have been described, and the probability to be associated with a malignancy can be high, intermediate and low. The top dermatoses that have been most associated with malignant neoplasm are: paraneoplasic acroqueratosis, acquired hypertrichosis lanuginosa, eritema gyratum repens and paraneoplastic pemphigus, which are described in this article, as well as paraneoplastic icthyosis.


REFERENCES

  1. Abreu Vélez, A.M. y Howard, M.S., “Diagnosis and treatment of cutaneous paraneoplastic disorders”, Dermatol Ther, 2010, 23 (6): 662-675. PubMed pmid: 21054710.

  2. Rivera Martínez, A.A., “Dermatosis paraneoplásicas. Revisión de la bibliografía”, en López Hernández, M.A. (ed.), México, Med Int Mex, 2011: 586-595.

  3. Pipkin, C.A. y Lio, P.A., “Cutaneous manifestations of internal malignancies: an overview”, Dermatol Clin, 2008, 26 (1): 1-15, vii. PubMed pmid: 18023767.

  4. Weiss, P. y O’Rourke, M.E., “Cutaneous paraneoplastic syndromes”, Clin J Oncol Nurs, 2000, 4 (6): 257-262. PubMed pmid: 11899323.

  5. Ivan, D., “Histopathology of inflammatory skin disease in oncological patients”, en Prieto, V.G. (ed.), Diagnostic histopathology, 2007: 203-212.

  6. Ehrst, B.D., Minzer-Conzetti, K., Swerdlin, A. y Devere, T.S., “Cutaneous manifestations of internal malignancy”, Curr Probl Surg, 2010, 47 (5): 384-445. PubMed pmid: 20363406.

  7. Ramos-E.-Silva, M., Carvalho, J.C. y Carneiro, S.C., “Cutaneous paraneoplasia”, Clin Dermatol, 2011, 29 (5): 541-547. PubMed pmid: 21855730.

  8. Bolognia, J.L., Brewer, Y.P. y Cooper, D.L., “Bazex syndrome (acrokeratosis paraneoplastic). An analytic review”, Medicine, 1991, 70 (4): 269-280. PubMed pmid: 2067411.

  9. Valdivielso, M., Longo, I., Suárez, R., Huerta, M. y Lázaro, P., “Acrokeratosis paraneoplastic: Bazex syndrome”, J Eur Acad Dermatol Venereol, 2005, 19 (3): 340-344. PubMed pmid: 15857461.

  10. Levine, D., Miller, S., Al-Dawsari, N., Barak, O. y Gottlieb, A.B., “Paraneoplastic dermatoses associated with gynecologic and breast malignancies”, Obstet Gynecol Surv, 2010, 65 (7): 455-461. PubMed pmid: 20723267.

  11. Dourmishev, L.A. y Draganov, P.V., “Paraneoplastic dermatological manifestation of gastrointestinal malignancies”, World J Gastroenterol, 2009, 15 (35): 4372-4379. PubMed pmid: 19764087. pmcid: pmc2747056.

  12. Eubanks, L.E., McBurney, E. y Reed, R., “Erythema gyratum repens”, Am J Med Sci, 2001, 321 (5): 302-305. PubMed pmid: 11370793.

  13. Kleyn, C.E., Lai-Cheong, J.E. y Bell, H.K., “Cutaneous manifestations of internal malignancy: diagnosis and management”, Am J Clin Dermatol, 2006, 7 (2): 71-84. PubMed pmid: 16605288.

  14. Anhalt, G.J., Kim, S.C., Stanley, J.R., Korman, N.J., Jabs, D.A., Kory, M. et al., “Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia”, N Engl J Med, 1990, 323 (25): 1729-1735. PubMed pmid: 2247105.

  15. Zhu, X. y Zhang, B., “Paraneoplastic pemphigus”, J Dermatol, 2007, 34 (8): 503-511. PubMed pmid: 17683379.

  16. Cho, Y.-T., Kao, J.-T., Chen, H.-J., Wang, L.-F. y Chu, C.-Y., “Paraneoplastic pemphigus: a retrospective case series in a referral center in northern Taiwan”, Dermatologica Sinica, 2014, 32 (1): 1-6.

  17. Kaplan, I., Hodak, E., Ackerman, L., Mimouni, D., Anhalt, G.J. y Calderón, S., “Neoplasms associated with paraneoplastic pemphigus: a review with emphasis on non-hematologic malignancy and oral mucosal manifestations”, Oral Oncol, 2004, 40 (6): 553-562. PubMed pmid: 15063382.

  18. Rueda Cadena, X. y Palma, L.F., “Pénfigo paraneoplásico”, Rev Asoc Col Dermatol, 2008, 16 (1): 42-44.

  19. Nguyen, V.T., Ndoye, A., Bassler, K.D., Shultz, L.D., Shields, M.C., Ruben, B.S. et al., “Classification, clinical manifestations and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus”, Arch Dermatol, 2001, 137 (2): 193-206. PubMed pmid: 11176692.

  20. Camisa, C. y Helm, T.N., “Paraneoplastic pemphigus is a distinct neoplasia- induced autoimmune disease”, Arch Dermatol, 1993, 129 (7): 883- 886. PubMed pmid: 8323311.

  21. Lee, S.E. y Kim, S.C., “Paraneoplastic pemphigus”, Dermatologica Sinica, 2010, 28 (1): 1-14. PubMed pmid: wos:000276114100001.

  22. Zapata, K.Z. y Ramírez, A.F., “Manifestaciones cutáneas de las neoplasias malignas”, Rev Asoc Col Dermatol, 2009, 17 (2): 109-120.

  23. Patel, N., Spencer, L.A., English, J.C. y Zirwas, M.J., “Acquired ichthyosis”, J Am Acad Dermatol, 2006, 55 (4): 647-656. PubMed pmid: 17010746.

  24. Moore, R.L. y Devere, T.S., “Epidermal manifestations of internal malignancy”, Dermatol Clin, 2008, 26 (1): 17-29, vii. PubMed pmid: 18023768.

  25. Song, Y.J., Wu, Y.F. y Fan, T., “Dermatosis as the Initial manifestation of malignant breast tumors: retrospective analysis of 4 cases”, Breast Care, 2010, 5 (3) :174-176. PubMed pmid: 21049066, pmcid: pmc2931057.




2020     |     www.medigraphic.com